Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...

The electrophysiologic mechanism may be due to either enhanced automaticity or triggered activity. In contrast to the paroxysmal variety, the nonparoxysmal type develops gradually and disappears ...

Untreated or unmanaged, SVT can lead to other possibly fatal heart abnormalities. Patients are advised to practice a cardiac-friendly diet and lifestyle (low sodium, little to no caffeine or alcohol, ...

Allied Market Research published a report, titled, "Cardiac Ablation Market by Product (Radiofrequency (RF) Ablators, ...

ST. LOUIS, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in ...

Initial strategy of catheter ablation leads to lower risk for composite primary end point versus antiarrhythmic drug therapy. (HealthDay News) — An initial strategy of catheter ablation leads to a ...

Deltona, Fla.-based Advanced Heart and Vascular Surgery Center, an affiliate of Cardiovascular Centers of America, has become the first ASC in Florida to launch a complete cardiac ablation service ...

Please provide your email address to receive an email when new articles are posted on . Patients with scar-related ventricular tachycardia (VT) who received VT ablation plus a subcutaneous ICD had ...

SAN FRANCISCO -- Noninvasive stereotactic radiotherapy (RT) for refractory ventricular tachycardia (VT) achieved outcomes similar to catheter ablation with substantially fewer serious adverse events ...

We demonstrated a significant rise in CRP at a median of 49 days after AF ablation. Although the subsequent decline in CRP observed at second follow-up (a median of 179 days after ablation) was not ...